131 related articles for article (PubMed ID: 11775539)
1. Platelet-derived growth factor and basic fibroblast growth factor immunolocalized in proliferative retinal diseases.
Liang X; Li C; Li Y; Huang J; Tang S; Gao R; Li S
Chin Med J (Engl); 2000 Feb; 113(2):144-7. PubMed ID: 11775539
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
3. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
Wang F; Xu X; Zhang X; Yan Y
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
5. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
Augustin AJ; Spitznas M; Koch F; Grus F; Böker T
Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
[TBL] [Abstract][Full Text] [Related]
7. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
8. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.
Carrington L; McLeod D; Boulton M
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1210-6. PubMed ID: 10752962
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
10. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
12. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
13. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders.
Cassidy L; Barry P; Shaw C; Duffy J; Kennedy S
Br J Ophthalmol; 1998 Feb; 82(2):181-5. PubMed ID: 9613386
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
Ikuno Y; Leong FL; Kazlauskas A
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
[TBL] [Abstract][Full Text] [Related]
15. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR).
Hueber A; Wiedemann P; Esser P; Heimann K
Int Ophthalmol; 1996-1997; 20(6):345-50. PubMed ID: 9237137
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
Heidenkummer HP; Kampik A; Petrovski B
Retina; 1992; 12(1):52-8. PubMed ID: 1565872
[TBL] [Abstract][Full Text] [Related]
18. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis.
Abu El-Asrar AM; Al-Mansouri S; Tabbara KF; Missotten L; Geboes K
Eye (Lond); 2006 Jan; 20(1):71-9. PubMed ID: 15746957
[TBL] [Abstract][Full Text] [Related]
20. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]